Their in vitro studies utilized TNFα and IL-17 as inflammatory stimuli, and their findings are in agreement with the above in vitro studies indicating that CF airway inflammation enhances the efficacy of CFTR modulators. The gene discussed is IL17A; the disease is cystic fibrosis.